C12Q 2561/113
Real time assay
C12Q2561/113 (Real time assay) appears on 72 US grants and 128 published applications in this corpus.
Search patents in C12Q- Granted patents
- 72
- Published applications
- 128
- Assignees
- 117
- Inventors
- 338
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 0 | 3 |
| 2013 | 0 | 8 |
| 2014 | 0 | 0 |
| 2015 | 5 | 3 |
| 2016 | 3 | 3 |
| 2017 | 1 | 3 |
| 2018 | 3 | 14 |
| 2019 | 0 | 7 |
| 2020 | 1 | 33 |
| 2021 | 16 | 21 |
| 2022 | 15 | 9 |
| 2023 | 8 | 5 |
| 2024 | 10 | 5 |
| 2025 | 3 | 2 |
| 2026 | 6 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for quantifying and/or detecting human male DNA6 Oct 2026US 12,753,430 B2Qiagen GmbH
- Double-functional oligonucleotide comprising complementary nucleotide sequence, mis-matched nucleotide sequence, reporter, and quencher, and a methods for nucleic acid amplification and measurement using the same4 Aug 2026US 12,698,525 B2Sd Biosensor, Inc.
- Cartridge for sample preparation and molecule analysis, cartridge control machine, sample preparation system and method using the cartridge30 Jun 2026US 12,667,845 B2STMicroelectronics S,r.l.
- Viability detection and quantification assay of waterborne pathogens by enrichment19 May 2026US 12,630,885 B2Phigenics, LLC
- HER2 heterogeneity as a biomarker in cancer3 Feb 2026US 12,540,359 B2Genentech, Inc.
- Kits and methods for diagnosing lung cancer9 Jul 2026US 2026/0193721 A1Nucleix Ltd.
- Her2 heterogeneity as a biomarker in cancer7 May 2026US 2026/0125767 A1Genentech, Inc.
- Archaeal polymerase amplification26 Feb 2026US 2026/0055445 A1Becton, Dickinson and Company
- Methods for treating endometriosis8 Jan 2026US 2026/0011411 A1Dot Laboratories, Inc.
- Treating patients harboring an isocitrate dehydrogenase-1 (idh-1) mutation1 Jan 2026US 2026/0000664 A1FORMA Therapeutics, Inc.
Most cited
By later US patents
- Methods for identifying nucleic acid modifications30US 9,175,341 B2Pacific Biosciences of California, Inc. · 2015
- Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method18US 11,130,994 B2Autonomous Medical Devices Inc. · 2021
- Devices for real-time polymerase chain reaction8US 10,006,861 B2Streck, Inc. · 2018
- Antisense modulation of pepck-cytosolic expression6US 6,187,545 B1Isis Pharmaceuticals, Inc. · 2001
- Methods for detecting analytes5US 11,001,881 B2California Institute of Technology · 2021